Alpharma Already Wants More From King (ALO, KG)
Alpharma, Inc. (NYSE: ALO) has already responded to King Pharmaceuticals Inc. (NYSE: KG) regarding the $33.00 per share offer made by King to acquire Alpharma. As we noted based upon ...Read Full Story »


